LMN-301

· Lumen Bioscience, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LMN-301, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Tolerability of Intranasal LMN-301 [Phase 1]